B cells play a complex role in the immune response. In addition to giving rise to plasma cells (PCs) and promoting T cell responses via antigen presentation, they perform immunoregulatory functions. This knowledge has created concerns regarding nonspecific B cell depletional therapy because of the potential to paradoxically augment immune responses. Recent studies now indicate that PCs have immune functions beyond immunoglobulin synthesis. Evidence for a new role for PCs as potent regulatory cells (via IL-10 and IL-35 production) is discussed including the implications for PC-targeted therapies currently being developed for clinical transplantation. In this new feature, the authors discuss the recent article "IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases" (Nature 2014; 507: 366-370) and its implications for transplantation.
CITATION STYLE
Woodle, E. S., & Rothstein, D. M. (2015, January 1). Clinical implications of basic science discoveries: Janus resurrected - Two faces of B cell and plasma cell biology. American Journal of Transplantation. Blackwell Publishing Ltd. https://doi.org/10.1111/ajt.13028
Mendeley helps you to discover research relevant for your work.